Detalles de la búsqueda
1.
Treatment and Survival of Elderly Patients with Stage I-II Pancreatic Cancer: A Report of the EURECCA Pancreas Consortium.
Ann Surg Oncol
; 27(13): 5337-5346, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32388741
2.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Lancet Oncol
; 19(11): 1459-1467, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348537
3.
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study.
Cancer
; 122(9): 1434-43, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26970343
4.
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.
Invest New Drugs
; 34(1): 119-28, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26643663
5.
The effect of prehabilitation on long-term survival and hospital admissions in older patients undergoing elective colorectal cancer surgery.
Eur J Surg Oncol
; 50(4): 108244, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452716
6.
The prognostic value of a geriatric risk score for older patients undergoing emergency surgery of colorectal cancer: A retrospective cohort study.
J Geriatr Oncol
; 15(2): 101711, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310662
7.
Surgical and non-surgical complications after colorectal cancer surgery in older patients; time-trends and age-specific differences.
Eur J Surg Oncol
; 49(4): 724-729, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635163
8.
Fostering Patient Choice Awareness and Presenting Treatment Options Neutrally: A Randomized Trial to Assess the Effect on Perceived Room for Involvement in Decision Making.
Med Decis Making
; 42(3): 375-386, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34727753
9.
Validation of the ACS NSQIP surgical risk calculator in older patients with colorectal cancer undergoing elective surgery.
J Geriatr Oncol
; 13(6): 788-795, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35466078
10.
Can physical prehabilitation prevent complications after colorectal cancer surgery in frail older patients?
Eur J Surg Oncol
; 47(11): 2830-2840, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34127328
11.
A Prediction Model for Severe Complications after Elective Colorectal Cancer Surgery in Patients of 70 Years and Older.
Cancers (Basel)
; 13(13)2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34206349
12.
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01).
Breast Care (Basel)
; 16(6): 598-606, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087363
13.
Risk prediction models for postoperative outcomes of colorectal cancer surgery in the older population - a systematic review.
J Geriatr Oncol
; 11(8): 1217-1228, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414672
14.
The impact of colorectal surgery on health-related quality of life in older functionally dependent patients with cancer - A longitudinal follow-up study.
J Geriatr Oncol
; 10(5): 724-732, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31076314
15.
A cost analysis of upfront DPYD genotype-guided dose individualisation in fluoropyrimidine-based anticancer therapy.
Eur J Cancer
; 107: 60-67, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30544060
16.
Methodology for senior-proof guidelines: A practice example from the Netherlands.
J Eval Clin Pract
; 24(1): 254-257, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28322487
17.
Risk stratification for surgical outcomes in older colorectal cancer patients using ISAR-HP and G8 screening tools.
J Geriatr Oncol
; 9(2): 110-114, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29129470
18.
Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical Trial.
JAMA Oncol
; 3(4): 501-508, 2017 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27918762
19.
Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.
Clin Cancer Res
; 9(1): 76-83, 2003 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-12538454
20.
Subcutaneous injection of interleukin 12 induces systemic inflammatory responses in humans: implications for the use of IL-12 as vaccine adjuvant.
Cancer Immunol Immunother
; 54(1): 37-43, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15693137